Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

http://www.wikidata.org/entity/Q41890535

about

The Role of MicroRNAs in Myeloproliferative Neoplasia Nanopharmacology in translational hematology and oncology MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma miR-181c associates with tumor relapse of high grade osteosarcoma MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib.RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.Function of extracellular vesicle-associated miRNAs in metastasis.miRNAs in chronic myeloid leukemia: small molecules, essential function.MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia.

P2860

Q26739435-7FCB52D7-8A50-4B21-8EFD-0E772747CD42 Q33961538-40F904F4-420C-4524-A7E9-DD45EEE7816F Q34253848-D8B385C5-677E-4733-A4CA-1C558EC1CF38 Q35987249-395671B2-691C-4BD5-B4AA-2829C46575B6 Q36334277-9EC5BFE9-2E44-4CEC-B09B-445AC57B9F0F Q37190370-C68E181D-596F-40AE-9B56-A18C6F8311F5 Q37421084-9DF8969D-EA79-44B0-B793-5903DED5A532 Q37644988-330E6710-4634-4D3E-9CC5-144A6888E98B Q38862245-F4E7B8D4-D4F2-4369-8EED-7C5346AC2442 Q38979577-B9510037-A62E-4BBF-AB65-F40F5ACCD391 Q42068004-1393F5AC-5C8F-470F-9CAA-B2119ABC4FD7 Q47216949-246182C7-0212-43C3-8A7D-8C6A01FB0202 Q47733035-86C187B0-E981-4239-8809-5FD22EDF1CFA Q53751456-F55D11F6-44BA-4F80-8446-FAED64108D28

P2860

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

http://www.wikidata.org/entity/Q41890535

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

@en

type

label

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

@en

prefLabel

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

@en

P1433

Q41890535-B4AFB0CC-A1BA-48D0-87E1-411363416679

P1476

Q41890535-CA8AAA2E-F320-459F-9AD3-AF0621595459

P2093

Q41890535-3791B8CE-2FEB-4C81-8D79-171D663119A7

Q41890535-384F176A-4B56-4A4B-80CD-48C07E8164AD

P2860

Q41890535-039DF5CD-7B85-46E1-AAD4-A3E2959A6A7C

Q41890535-0B441598-E6D0-4339-8552-DB65E1124865

Q41890535-0E0A0088-4F76-40B5-8699-4244866A29CA

Q41890535-2AE0DE80-7E7A-487C-B50E-49F5C6D0D4C0

Q41890535-2B29B911-0E11-4F9F-8FF8-FD8EAE097489

Q41890535-336F72A7-DCF5-430D-A4AB-2885C8E321D2

Q41890535-3E20E28F-D1DC-4248-BC90-4D0338C6B03B

Q41890535-49FAEDAB-73EB-4979-B915-CD2500E05838

Q41890535-4B8F5403-9BDE-41FB-ADC1-A66220CED13C

Q41890535-81F19811-BCA7-47B5-8E8F-613386313C2F

P2888

Q41890535-B376D5B8-DFB3-492D-8530-085BAC718DEB

P304

Q41890535-45EEA649-D014-45DD-B655-B29981EB1516

P31

Q41890535-DAD34CE8-C7F3-4BA4-84D2-AD8449D7B652

P356

Q41890535-C3658EDC-271B-4399-8C87-D6562559E7E1

P433

Q41890535-C22A27DE-A736-48C3-AB50-A8137E21CC0F

P478

Q41890535-1350B2A8-8070-4756-8F1E-BFA1C77728A0

P50

Q41890535-0686A46B-EA02-4FC9-9DC4-5C9A1EEE8A11

P577

Q41890535-823AF684-230A-458B-B676-55B29C390D61

P5875

Q41890535-8FC488BB-688F-4E53-866A-949245C0CF4F

P6179

Q41890535-35E599A4-DA93-4BA7-B744-1464356B718A

P698

Q41890535-E0BE67E1-18D8-4519-A7C2-23855DA4ECE6

P921

Q41890535-D44F71F2-41CE-4DA0-8CBE-25781E5B61F7

P932

Q41890535-CEEC7BEA-74A8-4898-AAAA-8726E148D19E

P356

P1433

Molecular Cytogenetics

P1476

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

@en

P2093

Neda Mosakhani

http://www.w3.org/2001/XMLSchema#string

Sakari Knuutila

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs modulate hematopoietic lineage differentiation

The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation

Detection of a microRNA signal in an in vivo expression set of mRNAs.

Non-coding RNAs for medical practice in oncology.

MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation.

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.

Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.

Expression patterns of microRNAs associated with CML phases and their disease related targets.

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.

P2888

P304

27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-8166-6-27

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250918733

http://www.w3.org/2001/XMLSchema#string

P6179

1045920208

http://www.w3.org/2001/XMLSchema#string

P698

23866735

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

3751646

http://www.w3.org/2001/XMLSchema#string